The Can B Corp.’s (OTCQB: CANB) Strategy Of Seed-To-Sale CBD Drives Company’s Vertically Integrated Success In Dynamic Market Compared To Competitors; Its Hemp-Sourced CBD Products Are Proprietary And Differentiated From Others In A Growth Industry Seen Reaching $30 Billion At Retail By 2023

In a competitive fast-growing CBD industry, The Can B Corp. (OTCQB: CANB) sets itself apart with a seed-to-sale marketing strategy that makes it vertically integrated and gives it hemp-sourced CBD products that are proprietary and differentiated from competitors. In a The Stock Market Podcast interview, Stanley Teeple, CFO and Director of the Company, said it can produce isolate and distillate through its own licensed processing facility and develop product lines truly its own.

The CBD market has drawn intense interest from media companies. stockmarketpress.com features specialized coverage of related stocks such as Can B Corp. (OTCQB: CANB), Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Cronos Group (NASDAQ: CRON), Canopy Growth Corp. (NYSE: CGC), Charlotte’s Web (OTC: CWBHF), INSYS Therapeutics, Inc. (NASDAQ: INSY), cbdMD (NYSE: YCBD), Joy Organics (NASDAQ: JOYG),, GW Pharmaceuticals (NASDAQ: GWPH) and Supreme Cannabis Co. (OTC: SPRWF).

The Can B Corp.’s (OTCQB: CANB) Strategy Of Seed-To-Sale CBD Drives Company’s Vertically Integrated Success In Dynamic Market Compared To Competitors; Its Hemp-Sourced CBD Products Are Proprietary And Differentiated From Others In A  Growth Industry Seen Reaching $30 Billion At Retail By 2023

Can B Corp. (OTCQB: CANB) markets CBD products under its own brands such as  Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. It markets to multi-channels including medical offices, doctor’s offices, retailers, online and direct. And this developing health and well company has a variety of other branding strategies, offering CBD products through proprietary licensed brands, white labels and private labels through third parties. In an interview with host Jane King on The Stock Market Podcast, Stanley Teeple, CFO, described the corporate structure of Can B Corp. (OTCQB: CANB) — and focused on the proprietary seed-to-sale hemp-sourced CBD products it offers. It has a GMP-compliant R&D and production facility in Lacey, Washington and Green Grow Farms, a licensed hemp grow and cultivation in New York.

Teeple said Can B Corp. (OTCQB: CANB) maintains its own quality control over its proprietary CBD product — always free from any hallucinogenic THC. Teeple explained that his company is in the health and wellness business, instead. The Can B Corp.’s (OTCQB: CANB) Strategy Of Seed-To-Sale CBD Drives Company’s Vertically Integrated Success In Dynamic Market Compared To Competitors; Its Hemp-Sourced CBD Products Are Proprietary And Differentiated From Others In A Growth Industry Seen Reaching $30 Billion At Retail By 2023.

Can B Corp. (OTCQB: CANB), with its focus on seed-to-sale, hemp-sourced CBD fully legal in all 50 states, is competing in a quick-growing CBD industry. Marijuana Business Daily projects that the CBD industry will reach $30 billion at retail by 2023. Not only are its CBD products proprietary to the Company, but Can B Corp. (OTCQB: CANB) documents its ingredients with ‘Certificates Of Analysis’ (COA’s) to document QC for its products in this relatively new industry now going mainstream. Retailers and consumer end-users can buy the Company’s CBD products with confidence because the company has lab-tested it for QC.

Marco Alfonsi, CEO, is optimistic about the future financial performance of Can B Corp. (OTCQB: CANB) due in part to the strong gross margins of almost 77% the CBD company achieved in its most recent reported financials for Q2 2020. In a report by site Bloomberg on CAN B Corp.’s (OTCQB: CANB) Q2 2020 financial results, the Company reported in the three month period ended June 30, 2020 that its gross profits rose 24% to 77% in 2020 from 53% in the comparable period in 2019.

Alfonsi, CEO of  Can B Corp. (OTCQB: CANB), said, “We remain enthusiastic about our business prospects and returning to growth mode. Given our strong gross margins of almost 77%, — 76.6% —  we feel confident in being able to return to the position we were earlier in 2020 when our revenue growth outpaced growth in expenses, as we achieved operating efficiencies.” The Can B Corp. (OTCQB: CANB) Strategy Of Seed-To-Sale CBD Drives Company’s Vertically Integrated Success In Dynamic Market Compared To Competitors; Its Hemp-Sourced CBD Products Are Proprietary And Differentiated From Others In A  Growth Industry Seen Reaching $30 Billion At Retail By 2023.

Extensive Lines Developed By This  Health And Wellness Emerging Growth Company

Can B Corp. (OTCQB: CANB) offers an extensive line of drops/tinctures, oils, creams, moisturizers, chews, isolate, gel caps, concentrates and more. Its diverse proprietary product lines are available under license, private label and branded labels. This health and wellness emerging growth company offers lines of hemp derived CBD, CBD and non-CBD under license for the Lifeguard® lifestyle brand, Canbiola branded through physicians, products through white label and private label plus other subsidiaries.

Can B Corp. (OTCQB: CANB) Offers An Extensive Line Of CBD Products. For more information about the Company and its extensive product lines, refer to its website at https://www.canbcorp.com/about-us/

Source: Stock Market Press

Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.

Contact:

Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com Safe Harbor Statement:

Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press